相关实验视频
Updated: May 21, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
糖尿病和怀孕:呼吁在临床实践中标准化术语
Edwin Augusto Acho Carranza1, Julio Alberto Leey Casella2, Marcio José Concepción-Zavaleta3
1Hospital Nacional Docente Madre Niño San Bartolomé, Lima, Perú, South America.
Diabetes research and clinical practice
|March 17, 2025
概括
这项研究提出了孕期糖尿病的清晰术语,将其分类为孕期糖尿病,早期妊娠糖尿病或晚期妊娠糖尿病. 统一的分类旨在减少混乱,并改善对母亲和胎儿结果的研究.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 怀孕期间糖尿病缺乏标准化术语导致临床混乱和研究挑战.
- 对于糖尿病并发症妊娠的现有术语是不一致的.
- 需要一个统一的分类系统来改善沟通和研究工作.
研究的目的:
- 提出一个标准化的妊娠糖尿病分类系统.
- 建立基于时间和诊断标准的清晰术语.
- 为全球关于妊娠糖尿病分类的共识提供基础.
主要方法:
- 关于孕期糖尿病的术语和分类现有文献的综述.
- 确定和提出四个不同的术语来分类怀孕期间的糖尿病.
主要成果:
- 建议的术语包括:孕期糖尿病 (怀孕前),早期怀孕糖尿病 (24周前),晚期怀孕糖尿病 (24周或之后) 和怀孕中的糖尿病 (任何怀孕年龄).
- 该提案侧重于分类,不包括病理生理机制或特定诊断标准.
结论:
- 对于妊娠糖尿病的普遍接受的术语是必不可少的.
- 标准化术语将减少临床混乱,并促进对并发症和产后进展的研究.
- 这种分类可以作为全球共识和改善患者护理的基础.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
837
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
837
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148

